Search Within

Ingo K Mellinghoff

  1. "2019"
Formats
  1. Meeting Abstract (9)
  2. Journal Article (6)
  3. Correspondence (2)
  4. Research Letter (2)
  5. Guidelines (1)
Groups
  1. GSK Faculty (20)
  2. Human Oncology and Pathogenesis Program (20)
  3. Tow Center for Developmental Oncology (TCDO) (20)
  4. Department of Pathology and Laboratory Medicine (7)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (5)
  6. Population Sciences Research Program (5)

More Groups

People
  1. Lisa De Angelis (7)
  2. Thomas Kaley (6)
  3. Christian Grommes (5)
  4. Alexandra Miller (4)
  5. Elena Pentsova (4)
  6. Marc Rosenblum (4)

More People

Years
  1. 2019 (20)
Publications
  1. Neuro-Oncology (5)
  2. Blood (2)
  3. Journal of Clinical Oncology (2)
  4. Nature Reviews Clinical Oncology (2)
  5. Clinical Cancer Research (1)
  6. European Journal of Nuclear Medicine and Molecular Imaging (1)

More Publications

Publishers
  1. Oxford University Press (6)
  2. Nature Publishing Group (5)
  3. American Society of Clinical Oncology (2)
  4. American Society of Hematology (2)
  5. Springer (2)
  6. American Association for Cancer Research (1)

More Publishers

Results (20)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase Ib of copanlisib in combination with ibrutinib in recurrent/refractory primary CNS lymphoma (PCNSL)
    Meeting Abstract

    Grommes, C.; Gavrilovic, I.; Miller, A. M.; Stone, J. B.; Kaley, T.; Madzsar, J. T.; Schumpp, A.; Butler, B. T.; Schaff, L.; Mellinghoff, I. K.
    Blood (2019)

    Fulltext@MSK | Save
  • AMG 596, a novel anti-EGFRvIII bispecific T cell engager (BiTE®) molecule for the treatment of glioblastoma (GBM): Planned interim analysis in recurrent GBM (rGBM)
    Meeting Abstract

    Rosenthal, M. A.; Balana, C.; van Linde, M. E.; Sayehli, C.; Fiedler, W. M.; Wermke, M.; Massard, C.; Mellinghoff, I. K.; Khasraw, M.; Ang, A.; more...
    Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • Prognostic and radiographic correlates of a prospectively collected molecularly profiled cohort of IDH-wildtype astrocytomas
    Meeting Abstract

    Lin, A.; Bale, T.; Mellinghoff, I.; Tabar, V.; Schaff, L.; Yang, T. J.; Young, R.; Taylor, B.; Rosenblum, M.; Jonsson, P.
    Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • Pamiparib in combination with radiation therapy (RT) and/or temozolomide (TMZ) in patients with newly diagnosed or recurrent/refractory (R/R) glioblastoma (GBM): Phase 1b/2 study update
    Meeting Abstract

    Piotrowski, A.; Puduvalli, V.; Wen, P.; Campian, J.; Colman, H.; Pearlman, M.; Butowski, N.; Battiste, J.; Glass, J.; Cloughesy, T.; more...
    Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • A phase 1, open-label, perioperative study of ivosidenib (AG-120) and vorasidenib (AG-881) in Recurrent IDH1 mutant, low-grade glioma: Updated results
    Meeting Abstract

    Mellinghoff, I.; Cloughesy, T.; Wen, P.; Taylor, J.; Maher, E.; Arrillaga-Romany, I.; Peters, K.; Choi, C.; Ellingson, B.; Lin, A.; more...
    Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • Extramammary Paget disease shows differential expression of B7 family members B7-H3, B7-H4, PD-L1, PD-L2 and cancer/testis antigens NY-ESO-1 and MAGE-A
    Journal Article

    Pourmaleki, M.; Young, J. H.; Socci, N. D.; Chiang, S.; Edelweiss, M.; Li, Y.; Zhang, M.; Roshal, L.; Chi, D. S.; Busam, K. J.; more...
    Oncotarget (2019)

    Fulltext@MSK | Save
  • A phase 1, open-label, perioperative study of ivosidenib (AG-120) and vorasidenib (AG-881) in recurrent, IDH1-mutant, low-grade glioma: Results from Cohort 1
    Meeting Abstract

    Mellinghoff, I. K.; Wen, P. Y.; Taylor, J. W.; Maher, E. A.; Arrillaga-Romany, I.; Peters, K. B.; Le, K.; Tai, F.; Steelman, L.; Cloughesy, T. F.
    Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • Prognostic value of FDG-PET/CT in recurrent/refractory CNS lymphoma receiving Ibrutinib-based therapies
    Meeting Abstract

    Krebs, S.; Wolfe, J.; Mellinghoff, I.; Grommes, C.; Schoder, H.
    European Journal of Nuclear Medicine and Molecular Imaging (2019)

    Fulltext@MSK | Save
  • A phase I, open label, perioperative study of AG-120 and AG-881 in recurrent IDH1 mutant, low-grade glioma: Results from cohort 1
    Meeting Abstract

    Mellinghoff, I. K.; Cloughesy, T. F.; Wen, P. Y.; Taylor, J. W.; Maher, E. A.; Arrillaga, I.; Peters, K. B.; Choi, C. H.; Ellingson, B. M.; Lin, A. P.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Letter: When less is more: Dexamethasone dosing for brain tumors
    Correspondence

    Lim-Fat, M. J.; Bi, W. L.; Lo, J.; Lee, E. Q.; Ahluwalia, M. S.; Batchelor, T. T.; Chang, S. M.; Chiocca, E. A.; Chukwueke, U.; Cloughesy, T. F.; more...
    Neurosurgery (2019)

    Fulltext@MSK | Save